{"title":"接受免疫治疗的患者中超进行性疾病与进行性疾病的差异","authors":"H. Yıldırım","doi":"10.14744/ejmo.2022.78280","DOIUrl":null,"url":null,"abstract":"DOI: 10.14744/ejmo.2022.78280 EJMO 2022;6(1):59–63 Eurasian Journal of Medicine and Oncology","PeriodicalId":11831,"journal":{"name":"Eurasian Journal of Medicine and Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"3","resultStr":"{\"title\":\"Differences between Hyperprogressive Disease and Progressive Disease in Patients Receiving Immunotherapy\",\"authors\":\"H. Yıldırım\",\"doi\":\"10.14744/ejmo.2022.78280\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"DOI: 10.14744/ejmo.2022.78280 EJMO 2022;6(1):59–63 Eurasian Journal of Medicine and Oncology\",\"PeriodicalId\":11831,\"journal\":{\"name\":\"Eurasian Journal of Medicine and Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-09-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"3\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Eurasian Journal of Medicine and Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.14744/ejmo.2022.78280\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Eurasian Journal of Medicine and Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.14744/ejmo.2022.78280","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
